Dynamic Contrast Enhanced MRI (DCE-MRI) Diffusion Weighted MRI (DW-MRI) and Magnetic Resonance Spectroscopy (MRS) of Head and Neck Tumors



Status:Recruiting
Conditions:Cancer, Obesity Weight Loss
Therapuetic Areas:Endocrinology, Oncology
Healthy:No
Age Range:18 - Any
Updated:3/6/2019
Start Date:February 2006
End Date:February 2020
Contact:Amita Dave, PhD
Phone:212-639-3184

Use our guide to learn which trials are right for you!

Magnetic resonance imaging (MRI) is a diagnostic study that makes pictures of organs of the
body using magnetic field and radio frequency pulses that can not be felt. Dynamic contrast
enhanced-magnetic resonance imaging (DCE-MRI) uses faster imaging and contrast material (a
substance used to make specific organs, blood vessels, or tumors easier to see) that is given
by vein. Diffusion weighted magnetic resonance imaging (DW-MRI) allows to measure the motion
of water around the cells in the tumor. Proton magnetic resonance spectroscopy (MRS) obtains
chemical information from the tumor. During MRS, signals are detected from the chemicals
(spectroscopy) naturally present in your tumor using radio waves. DCE-MRI, DW-MRI and MRS
give extra information which is not available with the regular MRI. The regular MRI only
shows pictures of the tumor while the DCE-MRI also gives information about the blood vessels
of the tumor. DW-MRI provides information related to the state of the tumor tissue with
regards to the quality or condition of cells present in it and MRS gives information about
the chemical makeup of the tumor.

The purpose of this study is to see whether DCE-MRI, DW-MRI and MRS done before treatment can
predict which patients will do well with either surgery or chemo-radiation therapy. This
study will also see if DCE-MRI, DW-MRI and MRS done early in treatment can tell if the
therapy is working.


Inclusion Criteria:

- Patients with histologically proven diagnosis of head and neck cancer or patients with
tumors strongly suspicious for head and neck cancer due to clinical features or FNA
(fine needle aspiration) cytology assessment.

- Will undergo surgery or chemo-radiation treatment

- Patients must be 18 years or older and have the ability to give informed consent

Exclusion Criteria:

- Claustrophobia

- Known reaction to Gd-DTPA

- Pre-operative radiation to primary tumor site

- Contraindication to MRI

1. Pacemaker

2. Aneurysmal clips

3. Metal implants in field of view

4. Pregnant or nursing women

5. Age and mental status wherein he/she is unable to cooperate for MRI study
We found this trial at
1
site
1275 York Ave
New York, New York 10021
(212) 639-2000
Principal Investigator: Amita Dave, PhD
Phone: 212-639-3184
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials